Sprinkles (HK) Charity Foundation Donates to The Education University of Hong Kong to Promote "Harmony between Humanity and Nature Sustainable Education" Project
HONG KONG, Dec. 23, 2025 /PRNewswire/ -- The Education University of Hong Kong (EdUHK) has received a donation of HK$2.95 million from the Sprinkles (HK) Charity Foundation ("Sprinkles") to develop the "Harmony between Humanity and Nature...
Gene Solutions Concludes Successful ESMO Asia Congress 2025 with AI-Powered Multi-Omics Liquid Biopsy Symposium and Two Best Poster Awards
SINGAPORE, Dec. 20, 2025 /PRNewswire/ -- Gene Solutions, a pioneering genetic testing company, announced key achievements at the European Society for Medical Oncology (ESMO) Asia Congress 2025—held in Singapore on December 5–7. Highlights included a...
Nabsys and Hitachi Present Electronic Genome Mapping Data at Japanese Society of Human Genetics (JSHG) 2025 Annual Meeting
TOKYO, Dec. 18, 2025 /PRNewswire/ -- Nabsys 2.0, LLC (Nabsys), a pioneer in electronic genome mapping technology, in partnership with Hitachi High-Tech Corporation (HHT) announces the presentation of high resolution structural variation data on the...
Cutting-Edge Technologies Debut in Concentration at 2025 AIE
MACAO, Dec. 17, 2025 /PRNewswire/ -- The 2025 Global Intelligent Machinery and Electronics Expo (AIE), organized by China Electronics Chamber of Commerce, is held in a "Macao + Zhuhai" dual-city format, covering an exhibition area of 70,000 square...
Rona Therapeutics Unveils the Global First Bi-valent PCSK9-LPA siRNA into Clinical Development for Cardiovascular Risk Reduction
SHANGHAI and SANTA BARBARA, Calif., Dec. 17, 2025 /PRNewswire/ -- Rona Therapeutics, a global leader in next-generation RNAi medicines, today announced the submission of RN5681 to the Australian Human Research Ethics Committee (HREC), advancing the...
iGreen Think Tank Releases Independent ESG Research, Highlighting China Overseas Land & Investment Ltd.'s Verified Low-Carbon and Governance Performance
SHENZHEN, China, Dec. 16, 2025 /PRNewswire/ -- iGreen Think Tank, an independent research institution specializing in sustainable development and ESG evaluation, has released its latest independent ESG research and quantitative assessment at the 3rd...
Breaking the "Untreatable": Biostar Pharma's UTD1 Achieves First Patient Dosing in U.S. for Pivotal Clinical Trial for Breast Cancer Brain Metastases
SAN FRANCISCO, Dec. 16, 2025 /PRNewswire/ -- Biostar Pharma, Inc., the U.S. wholly-owned subsidiary of Beijing Biostar Pharmaceuticals Co., Ltd. (Stock Code: 2563.HK), today announced that the first patient has been dosed for one of its key oversea...
Minghui Pharmaceutical Announces FDA clearance of IND to Initiate Global Phase Ⅲ Trials of MHB018A, a Subcutaneous Single-Domain IGF-1R Antibody, in Thyroid Eye Disease
SHANGHAI and HANGZHOU, China, Dec. 15, 2025 /PRNewswire/ -- Minghui Pharmaceutical, a late-stage biopharmaceutical company dedicated to developing transformative medicines in immunology and oncology, today announced the U.S. Food and Drug...
Global Spotlight｜POGMENT Biomimetic Collagen "Stable Triple Helix" Breakthrough Stuns the World--Extraordinary and Breathtaking
CHENGDU, China, Dec. 15, 2025 /PRNewswire/ -- Recently, LivingPhoenix Regenerative Technologies has captured widespread attention with its world-first "Stable Triple-Helix Biomimetic Collagen" technology, making consecutive appearances at 12...
Final Report Meeting on the Achievements of the Cheongju Craft Biennale 2025: Record-Breaking Economic Impact
- The achievement analysis report meeting took place on Wednesday, December 10, at 4:00 pm in the fourth-floor conference room of the Main Building, Culture Factory. - Visitor satisfaction reached 90.3%, and the economic ripple effect increased to...